ABOUT THIS EPISODE
A safer alternative exists - but why is it so often treated differently? When harm reduction depends on meeting people where they are, where do smokers fit in? The answer may challenge some long-held assumptions about nicotine, choice, and public health.
English
United States
TRANSCRIPT 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
OTHER EPISODES IN THIS PODCAST
Which oral nicotine products carry the greatest risk to oral health?
In this GFN Science Lab presentation, Helen Cowie examines how the shift from smoking to smokeless and oral nicotine products changes the way tobacco harm reduction should be assessed.
The discussion explores the current evidenc…
A clear and worsening division within public health has turned the debate over nicotine into a moral panic, with potentially dire consequences. Shot on location at GFN 2026 in Warsaw, Poland, longtime nicotine researcher and former University of Geneva professor of public health Jean-François Ette…
What Does Real-World Use Tell Us About Blu? | #GFN26ScienceLab by GFN.TV
A harm reduction approach should not stop at those who are still smoking. What about the millions who have already moved to safer nicotine products - and still depend on access to them? If public health is about reducing harm, shouldn’t their voices count too?
Disclaimer: The podcast and artwork embedded on this page are from GFN.TV, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.
EDIT
Thank you for helping to keep the podcast database up to date.
